Skip to main content
. 2018 Jul 31;35(8):1140–1152. doi: 10.1007/s12325-018-0753-6

Fig. 3.

Fig. 3

Patient satisfaction by inhaler type (visit 3, following 12 weeks’ treatment with the Bufomix Easyhaler®; visit 1 for other devices) (n = 1043). MDI metered dose inhaler